These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24613852)

  • 1. Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice.
    Boross P; Jansen JH; van Tetering G; Nederend M; Brandsma A; Meyer S; Torfs E; van den Ham HJ; Meulenbroek L; de Haij S; Leusen JH
    Immunol Lett; 2014 Aug; 160(2):151-7. PubMed ID: 24613852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.
    Albanesi M; Mancardi DA; Macdonald LE; Iannascoli B; Zitvogel L; Murphy AJ; Daëron M; Leusen JH; Bruhns P
    J Immunol; 2012 Dec; 189(12):5513-7. PubMed ID: 23150715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
    Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma.
    Bevaart L; Jansen MJ; van Vugt MJ; Verbeek JS; van de Winkel JG; Leusen JH
    Cancer Res; 2006 Feb; 66(3):1261-4. PubMed ID: 16452176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin.
    Murer P; Kiefer JD; Plüss L; Matasci M; Blümich SL; Stringhini M; Neri D
    J Invest Dermatol; 2019 Jun; 139(6):1339-1348. PubMed ID: 30543899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.
    Patel D; Bassi R; Hooper AT; Sun H; Huber J; Hicklin DJ; Kang X
    Anticancer Res; 2008; 28(5A):2679-86. PubMed ID: 19035294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of an autoantigenic 75-kDa human melanosomal glycoprotein.
    Vijayasaradhi S; Houghton AN
    Int J Cancer; 1991 Jan; 47(2):298-303. PubMed ID: 1671031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
    PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.
    Vijayasaradhi S; Bouchard B; Houghton AN
    J Exp Med; 1990 Apr; 171(4):1375-80. PubMed ID: 2324688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75.
    Vijayasaradhi S; Xu Y; Bouchard B; Houghton AN
    J Cell Biol; 1995 Aug; 130(4):807-20. PubMed ID: 7642699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice.
    Braster R; Bögels M; Benonisson H; Wuhrer M; Plomp R; Bentlage AEH; Korthouwer R; Visser R; Verbeek JS; van Egmond M; Vidarsson G
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.
    Hara I; Takechi Y; Houghton AN
    J Exp Med; 1995 Nov; 182(5):1609-14. PubMed ID: 7595233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV.
    Otten MA; van der Bij GJ; Verbeek SJ; Nimmerjahn F; Ravetch JV; Beelen RH; van de Winkel JG; van Egmond M
    J Immunol; 2008 Nov; 181(10):6829-36. PubMed ID: 18981101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma.
    Ly LV; Sluijter M; van der Burg SH; Jager MJ; van Hall T
    J Immunol; 2013 Jan; 190(1):489-96. PubMed ID: 23203930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immunity and autoimmunity induced by immunization with homologous DNA.
    Weber LW; Bowne WB; Wolchok JD; Srinivasan R; Qin J; Moroi Y; Clynes R; Song P; Lewis JJ; Houghton AN
    J Clin Invest; 1998 Sep; 102(6):1258-64. PubMed ID: 9739060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma.
    Hirschowitz EA; Leonard S; Song W; Ferris B; Leopold PL; Lewis JJ; Bowne WB; Wang S; Houghton AN; Crystal RG
    Gene Ther; 1998 Jul; 5(7):975-83. PubMed ID: 9813669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the gamma-chain from Fc(epsilon) RI.
    Mamalaki A; Gritzapis AD; Kretsovali A; Belimezi M; Papamatheakis J; Perez SA; Papamichail M; Baxevanis CN
    Cancer Immunol Immunother; 2003 Aug; 52(8):513-22. PubMed ID: 12715240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma.
    Ghanem G; Fabrice J
    Mol Oncol; 2011 Apr; 5(2):150-5. PubMed ID: 21324755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A melanosomal membrane protein is a cell surface target for melanoma therapy.
    Takechi Y; Hara I; Naftzger C; Xu Y; Houghton AN
    Clin Cancer Res; 1996 Nov; 2(11):1837-42. PubMed ID: 9816138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.